DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
dc.contributor.author | ARTIM-ESEN, Bahar | |
dc.contributor.author | Sahinkaya, YASEMİN | |
dc.contributor.author | KAMALI, Sevil | |
dc.contributor.author | TOZ, Bahtiyar | |
dc.contributor.author | PEHLIVAN, O. | |
dc.contributor.author | GUL, A. | |
dc.contributor.author | OCAL, L. | |
dc.contributor.author | YUCE, T. | |
dc.contributor.author | Erer, B. | |
dc.contributor.author | Bektas, M. | |
dc.contributor.author | INANC, Murat | |
dc.date.accessioned | 2021-03-02T23:24:48Z | |
dc.date.available | 2021-03-02T23:24:48Z | |
dc.identifier.citation | ARTIM-ESEN B., Sahinkaya Y., YUCE T., PEHLIVAN O., Bektas M., TOZ B., Erer B., KAMALI S., GUL A., OCAL L., et al., "DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME", Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1055 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_12438c0f-8169-45fd-aad8-e81bb4b02fb0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/17740 | |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2016-eular.5888 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF 240 PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 75 | |
dc.contributor.firstauthorID | 105242 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]